<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The monoclonal antibody D2-40 recognizes the membrane protein podoplanin, which is an established marker for <z:mpath ids='MPATH_310'>germ cell tumors</z:mpath>, <z:mpath ids='MPATH_365'>mesotheliomas</z:mpath>, and other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types and is also expressed in a variety of <z:mpath ids='MPATH_458'>normal</z:mpath> cells including follicular dendritic cells (<z:chebi fb="17" ids="38848">FDCs</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>To determine whether podoplanin represents an effective <z:chebi fb="17" ids="38848">FDC</z:chebi> marker for pathologic lymph nodes, we compared immunohistochemical studies (sensitivity, staining patterns, and intensity of staining) for podoplanin (D2-40) with those of the traditional <z:chebi fb="17" ids="38848">FDC</z:chebi> markers CD21, CD35, and clusterin </plain></SENT>
<SENT sid="2" pm="."><plain>Paraffin sections of 26 lymph nodes were analyzed, including 4 cases of nodular lymphocyte-predominant Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 4 angioimmunoblastic T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 8 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (including 3 cases with a component of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>), 5 hyaline-vascular <z:e sem="disease" ids="C0017531" disease_type="Disease or Syndrome" abbrv="GLNH|AFLH">Castleman disease</z:e>, and 5 reactive lymph nodes with <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, qualitatively and quantitatively podoplanin represented a highly effective marker for detection of <z:chebi fb="17" ids="38848">FDCs</z:chebi>, with staining intensity equal to or greater than that observed for other <z:chebi fb="17" ids="38848">FDC</z:chebi> markers </plain></SENT>
<SENT sid="4" pm="."><plain>This study demonstrates that podoplanin is an excellent marker for <z:chebi fb="17" ids="38848">FDCs</z:chebi> and adds to its growing list of diagnostic applications </plain></SENT>
</text></document>